Stimulation of matrix metalloproteinase-9 expression in human fibrosarcoma cells by synthetic matrix metalloproteinase inhibitors

Experimental Cell Research

Volumn 275, Issue 1, 2002, Pages 110-121

  Maquoi, Erik ^a,b,c   Munaut, Carine ^a,b,c   Colige, Alain ^a,b,c   Lambert, Charles ^a,b,c   Frankenne, Francis ^a,b,c   Noël, Agnès ^a,b,c   Grams, Frank ^a,b,c   Krell, Hans Willi ^a,b,c   Foidart, Jean Michel ^a,b,c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Invasion; MMP inhibitor; Plasminogen; Proteolysis; Transcriptional regulation; Tumor

Indexed keywords

BATIMASTAT; BETA GALACTOSIDASE; COLLAGEN TYPE 4; GELATINASE B; GI 129471; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE INHIBITOR; MESSENGER RNA; PLASMINOGEN; PRINOMASTAT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; [4 (N HYDROXYAMINO)ISOBUTYL(PHENYLTHIOMETHYL)SUCCINYL]PHENYLALANINE N METHYLAMIDE;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DNA FLANKING REGION; DNA TRANSCRIPTION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEADY STATE;

EID: 0036343580     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2002.5489     Document Type: Article

References (74)

1. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
2. Biology and biochemistry of proteinases in tumor invasion
3. The role of proteolytic enzymes in cancer invasion and metastasis
4. Matrix metalloproteinases: Multifunctional contributors to tumor progression
5. Association between expression of activated 72-kilodalton gelatinase and tumor spread in non-small-cell lung carcinoma
6. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
7. M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer
8. Molecular regulation of cellular invasion-role of gelatinase A and TIMP-2
9. Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay
10. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
11. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha
12. Regulation mechanism of 92-kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
13. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa MMP expression
14. Matrix metalloproteinases
15. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymatic properties
16. Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2
17. A matrix metalloproteinase expressed on the surface of invasive tumour cells
18. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
19. Tissue inhibitors of metalloproteinases: Evolution, structure and function
20. Clinical studies with matrix metalloproteinase inhibitors
21. Matrix metalloproteinase inhibition: A review of anti-tumor activity
22. Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer
23. Matrix metalloproteinase inhibitors
24. Development of matrix metalloproteinase inhibitors in cancer therapy
25. Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of tissue inhibitor of metalloproteinase 2 in human tumor cell lines
26. Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
27. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation
28. Affinity chromatography of plasminogen
29. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor
30. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension
31. Murine matrix metalloproteinase 9 gene: 5′ Upstream region contains cis-acting elements for expression in osteoclasts and migrating keratinocytes in transgenic mice
32. R-loop analysis of procollagen messenger RNA for the assessement of human collagen mutations
33. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells
34. Supernatants of acquired immunodeficiency syndrome-related kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness
35. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
36. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells
37. Tumor cell invasion inhibited by TIMP-2
38. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor
39. IL-10 blocks collagen IV invasion by "invasion stimulating factor" activated PC-3 ML cells: Upregulation of TIMP-1 expression
40. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
41. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: Isolation and characterization of the enzyme from HT1080 tumor cells
42. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells
43. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase
44. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells
45. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
46. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells
47. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
48. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes
49. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines
50. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease
51. Effects of tumour necrosis factor-alpha, interleukin-1 alpha, macrophage colony stimulating factor and transforming growth factor beta on trophoblastic matrix metalloproteinases
52. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells
53. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
54. Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices
55. Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases
56. Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNFα processing in RA synovial membrane cell cultures
57. A metalloproteinase inhibitor blocks the shedding of soluble cytokine receptors and processing of transmembrane cytokine precursors in human monocytic cells
58. Degradation of interleukin 1β by matrix metalloproteinases
59. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells
60. Functional overlap between two classes of matrix-degrading proteases in wound healing
61. Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis
62. Processing of tumour necrosis factor-α precursor by metalloproteinases
63. Membrane protein secretases
64. ECM and cell surface proteolysis: Regulating cellular ecology
65. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors
66. The discoidin domain receptor tyrosine kinases are activated by collagen
67. Preclinical and clinical studies of MMP inhibitors in cancer
68. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker
69. Activated gelatinase B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation
70. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo
71. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system
72. Functional role of matrix metalloproteinases (MMPs) in mammary epithelial cell development